Otrexup 20mg/0.4ml Pf Inj 4 X 0.4ml
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all the information provided. This medication is administered via injection into the fatty tissue of the skin, typically on the top of the thigh or in the belly area. If you will be self-administering the injection, your doctor or nurse will provide guidance on the proper technique.
Important Administration Guidelines
Do not inject the medication within 2 inches (5 cm) of the belly button.
Check the solution for cloudiness, leakage, or particles before use. If any of these conditions are present, do not use the medication.
Avoid injecting into skin that is irritated, tender, bruised, red, scaly, hard, scarred, or has stretch marks.
If you are unsure whether a dose was injected correctly or experience difficulty administering the dose, consult your doctor or pharmacist before using another dose.
Safe Disposal of Needles and Supplies
Dispose of used needles in a designated needle/sharp disposal box.
Do not reuse needles or other items.
When the disposal box is full, follow local regulations for proper disposal.
If you have any questions, consult your doctor or pharmacist.
Dosing and Frequency
Your dose and frequency of administration will be determined by your doctor based on the specific health condition being treated.
Important: This medication should never be taken daily unless prescribed for certain types of cancer. Incorrect use of this medication can lead to serious errors. Ensure you understand your dosing schedule and frequency before taking this medication. If you have any doubts, consult your doctor.
Monitoring and Adjustments
The way you take this medication may change based on blood work results, side effects, and how well the medication is working.
Handle this medication with care, and consult your doctor or pharmacist for guidance on proper handling.
Additional Recommendations
Drink plenty of non-caffeinated liquids, unless your doctor advises you to limit fluid intake.
Storage and Disposal
Store this medication at room temperature, protected from light, and in a dry place. Avoid storing it in a bathroom.
Missed Dose
* If you miss a dose, contact your doctor to determine the best course of action.
Lifestyle & Tips
- Take exactly as prescribed, usually once a week on the same day. Do NOT take daily.
- Take folic acid supplementation as directed by your doctor to reduce side effects (e.g., mouth sores, nausea).
- Avoid alcohol completely while on methotrexate due to increased risk of liver damage.
- Avoid prolonged sun exposure and use sunscreen, as methotrexate can increase sun sensitivity.
- Stay well-hydrated.
- Avoid live vaccines while on methotrexate, as your immune system may be weakened.
- Inform your doctor about all other medications, supplements, and herbal products you are taking.
- Use effective birth control during treatment and for at least 6 months after stopping for both men and women, as methotrexate can cause severe birth defects.
Available Forms & Alternatives
Available Strengths:
- Otrexup 10mg/0.4ml Pf Inj 4 X 0.4ml
- Otrexup 15mg/0.4ml Pf Inj 4 X 0.4ml
- Otrexup 20mg/0.4ml Pf Inj 4 X 0.4ml
- Otrexup 25mg/0.4ml Pf Inj 4 X 0.4ml
- Otrexup 10mg/0.4ml Inj, 0.4ml
- Otrexup 17.5mg/0.4ml Pf Injection
- Otrexup 12.5/0.4ml Inj, 0.4ml
- Otrexup 22.5/0.4ml Inj, 0.4ml
- Otrexup 17.5mg/0.4ml Pf Injection
- Otrexup 22.5/0.4ml Inj, 0.4ml
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
BLACK BOX WARNING
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor immediately or seek emergency medical attention:
Allergic Reaction: Rash, hives, itching, red, swollen, blistered, or peeling skin (with or without fever), wheezing, tightness in the chest or throat, difficulty breathing, swallowing, or talking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat.
Infection: Fever, chills, severe sore throat, ear or sinus pain, cough, increased or changed sputum production, painful urination, mouth sores, or a wound that won't heal.
Bleeding: Vomiting or coughing up blood, coffee ground-like vomit, blood in the urine, black, red, or tarry stools, gum bleeding, abnormal vaginal bleeding, unexplained bruises or bruises that enlarge, or uncontrollable bleeding.
Pancreatitis: Severe stomach pain, severe back pain, or severe nausea and vomiting.
Kidney Problems: Inability to urinate, changes in urine output, blood in the urine, or sudden weight gain.
Liver Problems: Dark urine, fatigue, decreased appetite, nausea or stomach pain, light-colored stools, vomiting, or yellow skin and eyes.
Lung or Breathing Problems: Shortness of breath, difficulty breathing, cough, or fever.
Nerve Problems: Abnormal burning, numbness, or tingling sensations; weakness; or paralysis (inability to move a body part).
Other Severe Symptoms: Pinpoint red spots on the skin, severe dizziness or fainting, seizures, confusion, excessive sleepiness, changes in vision, bone pain, or swelling, warmth, numbness, color changes, or pain in a leg or arm.
Stroke Symptoms: Weakness on one side of the body, difficulty speaking or thinking, balance changes, drooping on one side of the face, or blurred vision.
Other Concerning Symptoms: Headache, neck stiffness.
Other Possible Side Effects
Like all medications, this drug can cause side effects. Many people experience no side effects or only mild ones. If you're bothered by any of the following side effects or if they persist, contact your doctor:
Decreased appetite
Hair loss
Dizziness, fatigue, or weakness
Stomach pain
Common cold symptoms
This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Fever, chills, sore throat, or any signs of infection
- Unusual bleeding or bruising, black or tarry stools
- Severe or persistent diarrhea, nausea, vomiting
- Mouth sores, painful swallowing
- Shortness of breath, dry cough, or new chest pain
- Yellowing of skin or eyes, dark urine, severe fatigue (signs of liver problems)
- Swelling in ankles or feet, decreased urination (signs of kidney problems)
- Severe skin rash, blistering, or peeling
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
Certain health conditions, including:
+ Alcohol use disorder
+ Bone marrow disease, such as low white blood cell count, low platelet count, or anemia
+ Kidney disease
+ Liver disease
+ A weakened immune system
If you are breast-feeding, please note that you should not breast-feed while taking this medication. Additionally, you may need to avoid breast-feeding for a period after your last dose. Consult with your doctor to determine the necessary duration for avoiding breast-feeding after completing the medication.
This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health problems with your doctor and pharmacist. This will help ensure your safety while taking this medication. Do not initiate, stop, or modify the dosage of any medication without first consulting your doctor.
Precautions & Cautions
Before operating a vehicle or engaging in any activity that requires your full attention, wait until you understand how this medication affects you. Be aware that you may be more susceptible to infections, so it is crucial to practice good hygiene by washing your hands frequently and avoiding close contact with individuals who have infections, colds, or flu.
Due to the increased risk of bleeding, exercise caution to avoid injuries. To minimize this risk, use a soft-bristled toothbrush and an electric razor for shaving.
Prior to receiving any vaccinations, consult with your doctor, as certain vaccines may not be effective or may increase your risk of infection when taken with this medication. Additionally, discuss your alcohol consumption with your doctor before drinking.
You may be more prone to sunburn, so it is vital to limit your exposure to the sun, sunlamps, and tanning beds. Use protective measures such as sunscreen, clothing, and eyewear to shield yourself from the sun, and continue to take these precautions for the duration recommended by your doctor.
If you experience excessive fluid loss, unusual sweating, vomiting, diarrhea, decreased appetite, or excessive thirst, notify your doctor promptly. Be aware that this medication can cause severe nervous system problems, which may be temporary or long-lasting and can worsen over time. In some cases, these problems may not improve and can be life-threatening. If you have any concerns, discuss them with your doctor.
If you have undergone radiation therapy, inform your doctor. Individuals 65 years or older should use this medication with caution, as they may be more susceptible to side effects.
This medication may affect fertility, potentially leading to difficulties in becoming pregnant or fathering a child. It is unclear whether fertility will return to normal if this occurs. If you miss a menstrual period, have unprotected sex, or suspect that your birth control has failed, contact your doctor immediately.
Overdose Information
Overdose Symptoms:
- Severe myelosuppression (low white blood cells, red blood cells, platelets)
- Severe mucositis (mouth sores, gastrointestinal inflammation)
- Gastrointestinal bleeding
- Renal failure
- Hepatotoxicity
What to Do:
Immediately contact emergency services or poison control (Call 1-800-222-1222). Leucovorin rescue is the primary antidote, administered as soon as possible. Hydration and urinary alkalinization may also be used to enhance methotrexate elimination.
Drug Interactions
Contraindicated Interactions
- Live vaccines (in immunosuppressed patients)
- Trimethoprim/sulfamethoxazole (increased myelosuppression and methotrexate levels)
- Probenecid (decreased renal elimination of methotrexate)
- Non-steroidal anti-inflammatory drugs (NSAIDs) with high-dose methotrexate (severe, sometimes fatal, myelosuppression and nephrotoxicity)
- Salicylates (decreased renal elimination of methotrexate)
- Alcohol (increased risk of hepatotoxicity)
Major Interactions
- NSAIDs (with low-dose methotrexate: use with caution, monitor for toxicity, may increase methotrexate levels)
- Proton pump inhibitors (PPIs) (e.g., omeprazole, pantoprazole: may increase methotrexate levels, especially at higher doses)
- Retinoids (e.g., acitretin, etretinate: increased risk of hepatotoxicity)
- Other hepatotoxic drugs (e.g., azathioprine, leflunomide, sulfasalazine: increased risk of liver damage)
- Nephrotoxic drugs (e.g., aminoglycosides, cisplatin: impaired methotrexate elimination)
- Folic acid antagonists (e.g., pyrimethamine, trimethoprim: increased methotrexate toxicity)
- Phenytoin (decreased phenytoin levels, increased methotrexate toxicity)
- Theophylline (decreased theophylline clearance)
- Ciprofloxacin (may increase methotrexate levels)
Moderate Interactions
- Oral antibiotics (e.g., tetracyclines, chloramphenicol: may alter gut flora, affecting methotrexate absorption/enterohepatic recirculation)
- Penicillins (may decrease renal clearance of methotrexate)
- Sulfonamides (may displace methotrexate from protein binding, increasing free drug)
- Nitrous oxide (may potentiate methotrexate toxicity by inhibiting methionine synthase)
- Cholestyramine (may interfere with methotrexate absorption)
Minor Interactions
- Not typically categorized as minor due to high potential for significant interactions.
Monitoring
Baseline Monitoring
Rationale: To establish baseline hematologic status and detect pre-existing cytopenias. Methotrexate can cause myelosuppression.
Timing: Prior to initiation of therapy
Rationale: To establish baseline liver function. Methotrexate is hepatotoxic.
Timing: Prior to initiation of therapy
Rationale: To establish baseline renal function. Methotrexate is primarily renally eliminated, and impaired renal function increases toxicity.
Timing: Prior to initiation of therapy
Rationale: To establish baseline pulmonary status. Methotrexate can cause pulmonary toxicity.
Timing: Prior to initiation of therapy
Rationale: To screen for chronic viral hepatitis, which can increase risk of methotrexate-induced hepatotoxicity.
Timing: Prior to initiation of therapy
Routine Monitoring
Frequency: Weekly for the first month, then every 2-4 weeks for the next 2 months, then monthly or as clinically indicated.
Target: Maintain WBC > 3,000/mm³, ANC > 1,500/mm³, Platelets > 100,000/mm³.
Action Threshold: Hold dose for significant drops (e.g., WBC < 3,000/mm³, ANC < 1,500/mm³, Platelets < 100,000/mm³). Consider dose reduction or discontinuation.
Frequency: Every 2-4 weeks for the first 2 months, then monthly or as clinically indicated.
Target: AST/ALT < 2x upper limit of normal (ULN).
Action Threshold: Hold dose for persistent or significant elevations (e.g., AST/ALT > 2x ULN). Consider liver biopsy for persistent elevations or cumulative dose concerns.
Frequency: Monthly or as clinically indicated.
Target: Stable creatinine, within normal limits for patient.
Action Threshold: Hold dose for significant increase in creatinine (> 50% increase from baseline or above ULN). Adjust dose or discontinue.
Symptom Monitoring
- Signs of infection (fever, chills, sore throat)
- Unusual bleeding or bruising (petechiae, purpura)
- Severe or persistent diarrhea
- Oral ulcers or stomatitis (mouth sores)
- Shortness of breath, cough, or new onset dyspnea (signs of pulmonary toxicity)
- Yellowing of skin or eyes, dark urine (signs of hepatotoxicity)
- Severe skin reactions (rash, blistering)
- Nausea, vomiting, abdominal pain
- Fatigue, weakness
Special Patient Groups
Pregnancy
Contraindicated in pregnant women with non-oncologic diseases due to high risk of fetal death and severe congenital abnormalities. Category X.
Trimester-Specific Risks:
Lactation
Contraindicated. Methotrexate is excreted into breast milk and can cause serious adverse reactions in a breastfed infant.
Pediatric Use
Approved for polyarticular juvenile idiopathic arthritis (pJIA). Close monitoring for toxicity is essential. Long-term effects on growth and development should be considered.
Geriatric Use
Use with caution. Elderly patients may have decreased renal function, which can lead to increased methotrexate levels and toxicity. More susceptible to myelosuppression and hepatotoxicity. Lower doses or extended dosing intervals may be necessary.
Clinical Information
Clinical Pearls
- Methotrexate is dosed WEEKLY, not daily. Accidental daily dosing can be fatal.
- Folic acid supplementation (typically 1-5 mg once daily, or 5 mg once weekly on a different day than methotrexate) is crucial to reduce common side effects like mucositis, nausea, and liver enzyme elevations, without significantly reducing efficacy.
- Ensure adequate hydration to prevent renal toxicity.
- Strictly avoid alcohol due to the risk of severe hepatotoxicity.
- Patients must be educated on the signs and symptoms of toxicity and when to seek immediate medical attention.
- Regular and frequent monitoring of CBC, LFTs, and renal function is mandatory.
Alternative Therapies
- Other conventional synthetic DMARDs (csDMARDs): Hydroxychloroquine, Sulfasalazine, Leflunomide
- Biologic DMARDs (bDMARDs): TNF inhibitors (e.g., Adalimumab, Etanercept, Infliximab), IL-6 inhibitors (e.g., Tocilizumab), T-cell costimulation modulators (e.g., Abatacept), B-cell depleting agents (e.g., Rituximab)
- Targeted Synthetic DMARDs (tsDMARDs): JAK inhibitors (e.g., Tofacitinib, Baricitinib, Upadacitinib)
- For Psoriasis: Systemic therapies (e.g., cyclosporine, apremilast), biologics, phototherapy.